Relief Therapeutics Holding SA
SIX:RLF

Watchlist Manager
Relief Therapeutics Holding SA Logo
Relief Therapeutics Holding SA
SIX:RLF
Watchlist
Price: 2.8 CHF -1.41% Market Closed
Market Cap: 39.4m CHF

Wall Street
Price Targets

RLF Price Targets Summary
Relief Therapeutics Holding SA

There are no price targets for RLF.
Lowest
Price Target
Not Available
Average
Price Target
Not Available
Highest
Price Target
Not Available
Relief Therapeutics Holding SA Competitors:
Price Targets
TH
Theratechnologies Inc
24% Upside
TLX
Telix Pharmaceuticals Ltd
104% Upside
ALNY
Alnylam Pharmaceuticals Inc
4% Downside
ARQT
Arcutis Biotherapeutics Inc
35% Upside
ORKA
Oruka Therapeutics Inc
146% Upside
GRAL
Grail Inc
12% Upside
VRTX
Vertex Pharmaceuticals Inc
24% Upside
AREC
Arecor Therapeutics PLC
264% Upside

Revenue
Forecast

Revenue Estimate
Relief Therapeutics Holding SA

For the last 8 years the compound annual growth rate for Relief Therapeutics Holding SA's revenue is 121%. The projected CAGR for the next 1 year is 806%.

121%
Past Growth
806%
Estimated Growth
Estimates Accuracy
-74%
Average Miss

Operating Income
Forecast

Operating Income Estimate
Relief Therapeutics Holding SA

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
77%
Average Beat

Net Income
Forecast

Net Income Estimate
Relief Therapeutics Holding SA

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
N/A
Average
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is RLF's stock price target?
Not Available

RLF doesn't have any price targets made by Wall Street professionals.

What is Relief Therapeutics Holding SA's Revenue forecast?
Projected CAGR
806%

For the last 8 years the compound annual growth rate for Relief Therapeutics Holding SA's revenue is 121%. The projected CAGR for the next 1 year is 806%.

Back to Top